Propentofylline and Iloprost Suppress the Production of TNF-αby Macrophages but Fail to Ameliorate Experimental Autoimmune Encephalomyelitis in Lewis Rats

Swanborg, 1995, Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease, Clin. Immunol. Immunopathol., 77, 4, 10.1016/0090-1229(95)90130-2 Raine, 1992, Demyelinating diseases Ruddle, 1990, An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis, J. Exp. Med., 172, 1193, 10.1084/jem.172.4.1193 Hartung, 1992, Inflammatory mediators in demyelinating disorders of the CNS and PNS, J. Neuroimmunol., 40, 197, 10.1016/0165-5728(92)90134-7 Selmaj, 1995, Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I, J. Neuroimmunol., 56, 135, 10.1016/0165-5728(94)00139-F Hartung, 1995, Pathogenesis of inflammatory demyelination: implications for therapy, Curr. Opin. Neurol., 8, 191, 10.1097/00019052-199506000-00007 Moore, 1995, The role of cAMP regulation in controlling inflammation, Clin. Exp. Immunol., 101, 387, 10.1111/j.1365-2249.1995.tb03123.x Kammer, 1988, The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response, Immunol. Today, 9, 222, 10.1016/0167-5699(88)91220-0 Beavo, 1990, Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors, Trends Pharmacol. Sci., 11, 150, 10.1016/0165-6147(90)90066-H Novak, 1990, cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells, Proc. Natl. Acad. Sci. USA, 87, 9353, 10.1073/pnas.87.23.9353 Thanhauser, 1993, Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity, Immunology, 80, 151 Rott, 1993, Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats, Eur. J. Immunol., 23, 1745, 10.1002/eji.1830230802 Han, 1990, Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway, J. Exp. Med., 172, 391, 10.1084/jem.172.1.391 Sinha, 1995, Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids, Eur. J. Immunol., 25, 147, 10.1002/eji.1830250125 Eisenhut, 1993, Prostacyclin analogs suppress the synthesis of tumor necrosis factor-a in LPS-stimulated human peripheral blood mononuclear cells, Immunopharmacology, 26, 259, 10.1016/0162-3109(93)90042-O Grundmann, 1992, Inhibition of endotoxin-induced macrophage tumor necrosis factor expression by a prostacyclin analogue and its beneficial effect in experimental lipopolysaccharide intoxication, J. Infect. Dis., 165, 501, 10.1093/infdis/165.3.501 Snijdewint, 1993, Prostaglandin E2, J. Immunol., 150, 5321, 10.4049/jimmunol.150.12.5321 Betz, 1991, Prostaglandin E2, J. Immunol., 146, 108, 10.4049/jimmunol.146.1.108 Phipps, 1991, A new view of prostaglandin E regulation of the immune system, Immunol. Today, 12, 349, 10.1016/0167-5699(91)90064-Z Crutchley, 1994, Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-a and interleukin-1b in human monocytic THP-1 cells, J. Pharmacol. Exp. Ther., 271, 446 van der Pouw Kraan, 1995, Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production, J. Exp. Med., 181, 775, 10.1084/jem.181.2.775 Jung, 1996, Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats, J. Neuroimmunol., 68, 1, 10.1016/0165-5728(96)00051-3 Sommer, 1995, The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis, Nature Med., 1, 244, 10.1038/nm0395-244 Torphy, 1991, Phosphodiesterase inhibitors: new opportunities for the treatment of asthma, Thorax, 46, 512, 10.1136/thx.46.7.512 Robicsek, 1991, Multiple high-affinity cAMP phosphodiesterases in human T-lymphocytes, Biochem. Pharmacol., 42, 869, 10.1016/0006-2952(91)90047-9 Ichimura, 1993, A new cyclic nucleotide phosphodiesterase isoenzyme expressed in the T-lymphocyte cell lines, Biochem. Biophys. Res. Commun., 193, 985, 10.1006/bbrc.1993.1722 Meskini, 1994, Phosphodiesterases inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation, Biochem. Pharmacol., 47, 781, 10.1016/0006-2952(94)90477-4 Schroer, 1981, The antiplatelet and cardiovascular actions of a new carbocyclin derivative (ZK 36.374)—equipotent to PGI2, Naunyn-Schmiedeberg's Arch. Pharmacol., 316, 252, 10.1007/BF00505658 Eylar, 1971, Myelin basic proteins, Methods Enzymol., 32, 323, 10.1016/0076-6879(74)32034-4 Jung, 1995, Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2, Eur. J. Immunol., 25, 1391, 10.1002/eji.1830250538 Jung, 1994, Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat, Clin. Exp. Immunol., 98, 494, 10.1111/j.1365-2249.1994.tb05518.x Nataf, 1993, Pentoxifylline inhibits experimental allergic encephalomyelitis, Acta Neurol. Scand., 88, 97, 10.1111/j.1600-0404.1993.tb04198.x DeLeo, 1988, Protection against ischemic brain damage using propentofylline in gerbils, Stroke, 19, 1535, 10.1161/01.STR.19.12.1535 Dux, 1990, Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus, Brain Res., 516, 248, 10.1016/0006-8993(90)90925-2 Sliwa, 1991, Prevention of murine cerebral malaria by a stable prostacyclin analog, Infect. Immun., 59, 3846, 10.1128/IAI.59.10.3846-3848.1991 Utsunomiya, 1995, Attenuation of immune complex nephritis in NZB/W F1, Clin. Exp. Immunol., 99, 454, 10.1111/j.1365-2249.1995.tb05572.x Kelly, 1987, Prostaglandin E1, J. Clin. Invest., 79, 782, 10.1172/JCI112885 Tsuboi, 1996, Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isoenzymes types III and IV, J. Clin. Invest., 98, 262, 10.1172/JCI118788 Tobimatsu, 1985, Protective effect of prostaglandin E1, Surgery, 98, 45 Reder, 1994, Prostaglandins and inhibitors of arachidonate metabolism suppress experimental autoimmune encephalomyelitis, J. Neuroimmunol., 54, 117, 10.1016/0165-5728(94)90238-0 Huitinga, 1990, Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages, J. Exp. Med., 172, 1025, 10.1084/jem.172.4.1025 Rowles, 1986, The synergistic effect of cyclosporine and iloprost on survival of rat cardiac allografts, Transplantation, 42, 94, 10.1097/00007890-198607000-00024 Filipponi, 1989, Prolongation of guinea pig-to-rat xenograft survival with BN 52063, a specific antagonist of platelet-activating factor, Ital. J. Surg. Sci., 19, 325 MacPhee, 1988, Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets, J. Biol. Chem., 263, 10353, 10.1016/S0021-9258(19)81523-5 van Epps, 1981, Suppression of human lymphocyte migration by PGE2, Inflammation, 5, 81, 10.1007/BF00910782 Valitutti, 1993, Role of cAMP in regulating cytotoxic T lymphocyte adhesion and motility, Eur. J. Immunol., 23, 790, 10.1002/eji.1830230403 Oppenheimer-Marks, 1994, Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2, J. Immunol., 152, 5703, 10.4049/jimmunol.152.12.5703 Lidington, 1996, Inhibition of the transendothelial migration of human lymphocytes but not monocytes by phosphodiesterase inhibitors, Clin. Exp. Immunol., 104, 66, 10.1046/j.1365-2249.1996.d01-660.x Derian, 1995, Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators, J. Immunol., 154, 308, 10.4049/jimmunol.154.1.308 Griswold, 1993, Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response, Inflammation, 17, 333, 10.1007/BF00918994 To, 1990, Effect of leukotriene B42, Clin. Exp. Immunol., 81, 160, 10.1111/j.1365-2249.1990.tb05308.x Pober, 1993, Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, J. Immunol., 150, 5114, 10.4049/jimmunol.150.11.5114 Suttorp, 1993, Role of phosphodiesterases in the regulation of endothelial permeability in vitro, J. Clin. Invest., 91, 1421, 10.1172/JCI116346